PGE2 promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers

被引:58
|
作者
Jose Rodriguez-Lagunas, M. [1 ]
Martin-Venegas, Raquel [1 ]
Jose Moreno, Juan [1 ]
Ferrer, Ruth [1 ]
机构
[1] Univ Barcelona, Fac Farm, Dept Fisiol, E-08028 Barcelona, Spain
来源
关键词
paracellular permeability; intestine; tight junctions; eicosanoids; arachidonic acid cascade; PROTEIN-KINASE-A; TIGHT JUNCTION; PROSTAGLANDIN-E; TRANSEPITHELIAL RESISTANCE; PROSTANOID RECEPTORS; CA2+ RELEASE; E-2; EXPRESSION; MECHANISM; SUBTYPE;
D O I
10.1152/ajpcell.00397.2009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rodriguez-Lagunas MJ, Mart n-Venegas R, Moreno JJ, Ferrer R. PGE(2) promotes Ca2+-mediated epithelial barrier disruption through EP1 and EP4 receptors in Caco-2 cell monolayers. Am J Physiol Cell Physiol 299: C324-C334, 2010. First published May 19, 2010; doi: 10.1152/ajpcell.00397.2009.-We recently demonstrated that PGE(2) induces the disruption of the intestinal epithelial barrier function. In the present study, our objectives were to study the role of PGE(2) receptors (EP1-EP4) and the signaling pathways involved in this event. Paracellular permeability (PP) was assessed in differentiated Caco-2 cell cultures from D-mannitol fluxes and transepithelial electrical resistance (TER) in the presence of different PGE(2) receptor agonists (carbacyclin, sulprostone, butaprost, ONO-AE1-259, ONO-AE-248, GR63799, and ONO-AE1-329) and antagonists (ONO-8711, SC-19220, AH-6809, ONO-AE3-240, ONO-AE3-208, and AH-23848). The results indicate that EP1 and EP4 but not EP2 and EP3 might be involved in PP regulation. These effects were mediated through PLC-inositol trisphosphate (IP3)-Ca2+ and cAMP-PKA signaling pathways, respectively. We also observed an increase in intracellular Ca2+ concentration ([Ca2+](i)) strengthened by cAMP formation indicating a cross talk interaction of these two pathways. Moreover, the participation of a conventional PKC isoform was shown. The results also indicate that the increase in PP may be correlated with the redistribution of occludin, zona occludens 1 (ZO-1), and the perijunctional actin ring together with an increase in myosin light chain kinase activity. Although the disruption of epithelial barrier function observed in inflammatory bowel disease (IBD) patients has been traditionally attributed to cytokines, the present study focused on the role of PGE(2) in PP regulation, as mucosal levels of this eicosanoid are also increased in these inflammatory processes.
引用
收藏
页码:C324 / C334
页数:11
相关论文
共 50 条
  • [1] PGE2 promotes angiogenesis through EP4 and PKACγ pathway
    Zhang, Yushan
    Daaka, Yehia
    BLOOD, 2011, 118 (19) : 5355 - 5364
  • [2] Synthesis and evaluation of γ-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists
    Kambe, Tohru
    Maruyama, Toru
    Nakai, Yoshihiko
    Oida, Hiroji
    Maruyama, Takayuki
    Abe, Nobutaka
    Nishiura, Akio
    Nakai, Hisao
    Toda, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (11) : 3502 - 3522
  • [3] Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists
    Zhao, Zhong
    Araldi, Gian Luca
    Xiao, Yufang
    Reddy, Adulla P.
    Liao, Yihua
    Karra, Srinivasa
    Brugger, Nadia
    Fischer, David
    Palmer, Elizabeth
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) : 6572 - 6575
  • [4] PGE2 induces monocyte drived dendritic cell maturation via EP2 and EP4 receptors.
    Kubo, S
    Takahashi, H
    Yokoyama, A
    Yokoyama, M
    Shuji, M
    Nishibori, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 281P - 281P
  • [5] Binary regulation of interleukin(IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1β-stimulated human gingival fibroblasts
    Noguchi, K
    Shitashige, M
    Endo, H
    Kondo, H
    Ishikawa, I
    JOURNAL OF PERIODONTAL RESEARCH, 2002, 37 (01) : 29 - 36
  • [6] PGE2 decreases reactivity of human platelets by activating EP2 and EP4
    Smith, James P.
    Haddad, Elias V.
    Downey, Jason D.
    Breyer, Richard M.
    Boutaud, Olivier
    THROMBOSIS RESEARCH, 2010, 126 (01) : E23 - E29
  • [7] Expression of the prostaglandin E2 receptors EP1, EP2, EP3 and EP4 in human kidney
    Morath, R
    Klein, T
    Seyberth, HW
    Nüsing, RM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R725 - R725
  • [8] Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer
    Doherty, Glen A.
    Byrne, Sinead M.
    Molloy, Eamonn S.
    Malhotra, Vikrum
    Austin, Sandra C.
    Kay, Elaine W.
    Murray, Frank E.
    Fitzgerald, Desmond J.
    BMC CANCER, 2009, 9
  • [9] PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors
    Safholm, J.
    Dahlen, S-E
    Delin, I.
    Maxey, K.
    Stark, K.
    Cardell, L-O
    Adner, M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (04) : 794 - 806
  • [10] Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis
    Arosh, Joe A.
    Lee, JeHoon
    Balasubbramanian, Dakshnapriya
    Stanley, Jone A.
    Long, Charles R.
    Meagher, Mary W.
    Osteen, Kevin G.
    Bruner-Tran, Kaylon L.
    Burghardt, Robert C.
    Starzinski-Powitz, Anna
    Banu, Sakhila K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (31) : 9716 - 9721